China

AB-Biotics to launch gastropaedriatric probiotic with Derbycare

03-Mar-2015 - Last updated on 03-Mar-2015 at 16:02 GMT

AB-Kolicare reduces excessive crying as a result of baby colic

AB-Biotics, the Spanish biotech company, and leading Chinese women and infant nutrition player Derbycare will launch a gastropaediatric health product in China this year.

Before the launch, Derbycare will develop three new clinical trials with a minimum of 3,000 patients to cement the claims of the product, AB-Kolicare.

Among these is the reduction of excessive daily crying in two-thirds subjects over 14 days, according to an AB-Biotics clinical trial.

Derbycare and AB-Biotics will also collaborate on the development of new probiotic formulas and food supplements rich in probiotics for infants which Derbycare will market in China and other markets.

Derbycare owns a paediatric nutrition research institute with an independent expert committee and an advisory team including representatives from major Chinese hospitals.

"This agreement allows AB-Biotics to enter the Chinese paediatric market with an excellently positioned partner that will also allow us to develop new innovative solutions thanks to its excellent research institute", said Miquel Angel Bonachera and Sergi Audivert, chief executives of of AB-Biotics.

Jason Shen, executive director of Derbycare, responded: “Derbycare will work closely with AB-Biotics to promote the probiotic products among the maternity and 0-3 infant population in China, a 70m population who know little about probiotics and seldom use them. This is a huge opportunity.”